Prosthetic Valve Selection and Durability in Young Patients With Connective Tissue

Joshua Norton Background.  Young patients with connective tissue disorders (CTDs) create a unique challenge for valve selection due to abnormal tissue biology, long life expectancy, re-intervention risk, anticoagulation considerations, and patient priorities such as lifestyle and pregnancy. [1, 2] Current ACC/AHA and ESC/EACTS guidelines emphasize patient-centered care but provide little…
Cardiology Engineering Medicine Featured Abstracts

Prehospital Blood Product Transfusion in Traumatic Hypovolemic Shock: Advantages Over Crystalloid Resuscitation and Implications for Rural Trauma Care

Aaron Spearman Background: Traumatic hypovolemic shock remains a major cause of preventable early death after injury, and prehospital resuscitation strategy can significantly affect survival1. Recent trauma literature has moved away from large-volume crystalloid resuscitation because crystalloids do not restore oxygen-carrying capacity or coagulation factors and may worsen dilutional coagulopathy1. In…
Cardiology Engineering Medicine Featured Abstracts

m6A RNA Modification in Cardiac Remodeling and Heart Failure

Priya Modi Background: Heart failure (HF) is a chronic progressive syndrome affecting more than six million adults in the United States and is associated with significant morbidity, mortality, and healthcare costs.¹ Current guideline-directed medical therapies improve survival by targeting neurohormonal pathways but do not directly address the underlying molecular drivers…
Cardiology Featured Abstracts

From weight loss to cardiovascular risk reduction: should GLP‑1/GIP obesity therapy change routine cardiometabolic care?

Rachel Kurian Background:  Obesity is a growing global health concern, with adult prevalence roughly doubling since 1990.1 Recently, anti‑obesity medications such as semaglutide and tirzepatide have produced weight loss of approximately 15–20% of initial body weight.2, 3 Semaglutide, a glucagon‑like peptide‑1 (GLP‑1) receptor agonist (RA), enhances glucose‑dependent insulin secretion and…
Cardiology Engineering Medicine Featured Abstracts

Emerging Roles of CRISPR Gene Editing in Cardiovascular Disease Research and Therapy

Fouzul Kansul Background: Cardiovascular disease (CVD) is a leading cause of global morbidity and mortality, accounting for nearly 20 million deaths per year [1,2]. Despite significant advancements in pharmacologic and interventional therapies, CVD treatments primarily target symptoms rather than underlying genetic causes [1-3]. CRISPR-Cas9, an RNA-guided genome editing tool, has…
Cardiology Engineering Medicine Featured Abstracts

Pressure-Sensitive Multivesicular Liposomes for Targeted Drug Delivery in High-Altitude Pulmonary Edema

Ethan Edwards Background: High-Altitude Pulmonary Edema (HAPE) is a life-threatening condition caused by abnormal pulmonary vasoconstriction in hypoxic environments. Exposure to elevations above 3,000 m is increasing due to growing participation in high-altitude travel and sports, placing a larger population at risk for HAPE.1 The purpose of this abstract is…
Cardiology Engineering Medicine Featured Abstracts

Beyond CTA: Imaging Guideline Considerations After Endovascular Aneurysm Repair

Stephan Bannikov Background:  Endovascular aneurysm repair (EVAR) has become critical in the treatment of infrarenal abdominal aortic aneurysms because of its reduced perioperative morbidity compared to open repair.1,2 These interventions, while effective, require continuous postoperative monitoring for complications such as endoleaks.3 The current approach centers around computed tomography angiography (CTA)…
Cardiology Engineering Medicine Featured Abstracts

Endothelial-to-Mesenchymal Transition as a Driver and Therapeutic Target in Cardiac Valvular Fibrosis

Aidan Atkins Background: Endothelial‑to‑mesenchymal transition (EndMT) is a phenotypic switch in which endothelial cells lose markers such as CD31 and VE‑cadherin and acquire mesenchymal features, including α‑smooth muscle actin, vimentin, and N‑cadherin.1 Although EndMT is required for normal valvulogenesis, its reactivation in adult tissues has been linked to myocardial fibrosis,…
Cardiology Engineering Medicine Featured Abstracts

Radiation Induced Coronary Artery Disease From Endothelial Activation to Fibrotic Plaque: Molecular Mechanisms and Radiomic-Guided Prevention

Nadean Zahra Background: Radiation-induced coronary artery disease (RICAD) is a growing cardiovascular disease seen in those who use thoracic radiotherapy, such a breast cancer survivors.1 Unlike traditional coronary artery disease (CAD), RICAD is has diffuse fibrotic plaque formation at proximal and ostials. RICAD is a diagnostic challenge because of its…
Cardiology Featured Abstracts

Radiation-Induced Coagulopathy in Space Medicine: Bridging Early DIC Detection With Mechanistic Animal and Human Biomarker Data

Isaac Ponder Background: Disseminated intravascular coagulation (DIC) is an acquired syndrome of systemic coagulation activation that may cause thrombosis, bleeding, and organ failure. Diagnosis relies on an inciting condition with evolving abnormalities in platelet count, prothrombin time, fibrinogen, and fibrin-related markers, while treatment remains largely directed at the underlying trigger.…
Cardiology